选择性肠系膜上动脉输注重组组织型纤溶酶原激活剂治疗门静脉血栓形成
Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator.
作者信息
Henao E A, Bohannon W Todd, Silva M B
机构信息
Division of Vascular Surgery, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430-8312, USA.
出版信息
J Vasc Surg. 2003 Dec;38(6):1411-5. doi: 10.1016/s0741-5214(03)01052-8.
Portal and mesenteric venous thrombosis is an uncommon condition that is usually treated with systemic anticoagulation. Catheter-directed thrombolysis via the superior mesenteric artery may be a viable adjunct to treatment of this potentially morbid condition. We present a case of portal and mesenteric venous thrombosis treated with systemic anticoagulation and catheter-directed infusion of tissue plasminogen activator via the superior mesenteric artery.
门静脉和肠系膜静脉血栓形成是一种罕见疾病，通常采用全身抗凝治疗。经肠系膜上动脉进行导管定向溶栓可能是治疗这种潜在致命疾病的一种可行辅助方法。我们报告一例门静脉和肠系膜静脉血栓形成病例，该病例采用全身抗凝治疗，并经肠系膜上动脉进行导管定向输注组织型纤溶酶原激活剂。
Zotero 插件